Furthermore, a recent study demonstrated that the elevation of serum ALT levels was linked to hyperglycemia in T2DM patients and that silencing both ALT isoforms could retard hyperglycemia in T2DM mouse models via chronic glucocorticoid and glucagon signaling [53]. This evidence concerns the gene GPT and type 2 diabetes mellitus.